Gary Gensler said his team’s review of a controversial Ethereum ETF application was going smoothy, despite early indications the SEC viewed Ethereum as a security.
Blockbuster obesity drug Wegovy has been approved in China, opening the door for maker Novo Nordisk to begin selling it in the world’s second-largest economy, where the appetite for similar treatments is surging.